Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05799313 · ClinicalTrials.gov registry record · NA

Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead

A NA study of Overactive Bladder, sponsored by The Cleveland Clinic.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05799313 is a NA study of Overactive Bladder that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 30 participants, below the 211-participant average among 45 other Overactive Bladder trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05799313, a NA study of Overactive Bladder, is actively recruiting participants, sponsored by The Cleveland Clinic.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

For women undergoing percutaneous nerve evaluation (PNE) for the treatment of overactive bladder the first step is the PNE interstim therapy trial. If the PNE works, patients may opt to have the interstim procedure. The purpose of this study is to see if patients who remove their PNE lead at home have the same satisfaction with the PNE trial as those women who have their lead removed in the office.

Conditions Studied

Interventions

  • OTHER At home removal
  • OTHER In office removal

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-06-07
Est. Completion 2026-12-31
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT05799313

The ClinicalTrials.gov registry entry for NCT05799313 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 211-participant average among 45 other Overactive Bladder trials with a reported enrollment target (86% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Overactive Bladder appearing as the primary indexed condition, and to 2 interventions - of which At home removal is the first listed.

NCT05799313 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05799313 about?

NCT05799313 is a clinical study titled "Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead". For women undergoing percutaneous nerve evaluation (PNE) for the treatment of overactive bladder the first step is the PNE interstim therapy trial. If the PNE works, patients may opt to have the interstim procedure. The purpose of this study is to see if patients who remove their PNE lead at home ha...

What is the current status of trial NCT05799313?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-06-07. Estimated completion is 2026-12-31.

What conditions does trial NCT05799313 study?

This clinical trial studies the following conditions: Overactive Bladder.

What interventions are being tested in trial NCT05799313?

The interventions under investigation include: At home removal (OTHER), In office removal (OTHER).

Who is sponsoring clinical trial NCT05799313?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05799313 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overactive Bladder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.